FASEB J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Saleh, D.
Right arrow Articles by Giaid, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Saleh, D.
Right arrow Articles by Giaid, A.
(The FASEB Journal. 1998;12:929-937.)
© 1998 FASEB

RESEARCH COMMUNICATION

Increased formation of the potent oxidant peroxynitrite in the airways of asthmatic patients is associated with induction of nitric oxide synthase: effect of inhaled glucocorticoid

Dina Saleha, Pierre Ernsta, Sam Limb, Peter J. Barnesb, and Adel Giaida,1

a Departments of Medicine and Pathology, The Montreal General Hospital, McGill University, Montreal, Quebec, Canada H3G 1A4; GenPath Laboratories, Montreal, Quebec, Canada
b National Heart and Lung Institute, London, England

Peroxynitrite is a potent oxidant formed by the rapid reaction of the free radicals nitric oxide (NO) and superoxide. It causes airway hyperresponsiveness and airway epithelial damage, enhances inflammatory cell recruitment, and inhibits pulmonary surfactant. Asthma is characterized by increased airway hyperresponsiveness, airway epithelial shedding, and inflammation. We examined the production of peroxynitrite and the expression of inducible nitric oxide synthase (iNOS) in airways of asthmatic patients compared to normal control subjects. We also performed a double-blind, crossover randomized-order, placebo-controlled study on 10 asthmatic patients to study the effects of inhaled glucocorticoid treatment (Budesonide) on the formation of peroxynitrite and NO. Fiberoptic bronchial biopsies were examined by immunohistochemistry with antiserum to nitrotyrosine, a marker of protein nitration by peroxynitrite. We also examined the expression of iNOS by immunohistochemistry and in situ hybridization, and measured exhaled NO by chemiluminescence. We correlated the airway production of peroxynitrite with pulmonary functions and airway responsiveness. In airway passages of control subjects, there was weak or no nitrotyrosine immunoreactivity. In contrast, there was strong immunoreactivity for nitrotyrosine in the airway epithelium and inflammatory cells in the airways of persons with asthma. Budesonide treatment resulted in a significant reduction in nitrotyrosine immunoreactivity. Expression of iNOS was evident in the airway pithelium of controls and asthmatic patients, but was significantly more abundant in asthmatic patients. The presence of nitrotyrosine in the airway epithelium (r=-0.841, P<0.0001; r=-0.771, P=0.0004) and inflammatory cells (r=-0.727, P=0014; r=-0.681, P=0.004) correlated inversely with methacholine PC20 and forced expiratory volume in 1 s, respectively. Asthma is associated with increased peroxynitrite formation in the airways, which is reduced after Budesonide treatment. The potent oxidant peroxynitrite may contribute to airway obstruction and hyperresponsiveness and epithelial damage in asthma.—Saleh, D., Ernst, P., Lim, S., Barnes, P. J., Giaid, A. Increased formation of the potent oxidant peroxynitrite in the airways of asthmatic patients is associated with induction of nitric oxide synthase: effect of inhaled glucocorticoid. FASEB J. 12, 929–937 (1998)


Key Words: nitrotyrosine • asthma • steroids • human




This article has been cited by other articles:


Home page
 J. Immunol.Home page
K. Ckless, A. Lampert, J. Reiss, D. Kasahara, M. E. Poynter, C. G. Irvin, L. K. A. Lundblad, R. Norton, A. van der Vliet, and Y. M. W. Janssen-Heininger
Inhibition of Arginase Activity Enhances Inflammation in Mice with Allergic Airway Disease, in Association with Increases in Protein S-Nitrosylation and Tyrosine Nitration
J. Immunol., September 15, 2008; 181(6): 4255 - 4264.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
H. Meurs, R. Gosens, and J. Zaagsma
Airway hyperresponsiveness in asthma: lessons from in vitro model systems and animal models
Eur. Respir. J., August 1, 2008; 32(2): 487 - 502.
[Abstract] [Full Text] [PDF]

Home page
 Therapeutic Advances in Respiratory DiseaseHome page
A. Nadeem, A. Masood, and N. Siddiqui
Review: Oxidant--antioxidant imbalance in asthma: scientific evidence, epidemiological data and possible therapeutic options
Therapeutic Advances in Respiratory Disease, August 1, 2008; 2(4): 215 - 235.
[Abstract] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
K. Takemoto, K. Ogino, M. Shibamori, T. Gondo, Y. Hitomi, T. Takigawa, D.-H. Wang, J. Takaki, H. Ichimura, Y. Fujikura, et al.
Transiently, paralleled upregulation of arginase and nitric oxide synthase and the effect of both enzymes on the pathology of asthma
Am J Physiol Lung Cell Mol Physiol, December 1, 2007; 293(6): L1419 - L1426.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
D. Singh, D. Richards, R. G. Knowles, S. Schwartz, A. Woodcock, S. Langley, and B. J. O'Connor
Selective Inducible Nitric Oxide Synthase Inhibition Has No Effect on Allergen Challenge in Asthma
Am. J. Respir. Crit. Care Med., November 15, 2007; 176(10): 988 - 993.
[Abstract] [Full Text] [PDF]

Home page
 GlycobiologyHome page
A. P Rogerio, C. R Cardoso, C. Fontanari, M. A Souza, S. R Afonso-Cardoso, E. V. Silva, N. S Koyama, F. L Basei, E. G Soares, J. B Calixto, et al.
Anti-asthmatic potential of a D-galactose-binding lectin from Synadenium carinatum latex
Glycobiology, August 1, 2007; 17(8): 795 - 804.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. Nadeem, M. Fan, H. R. Ansari, C. Ledent, and S. Jamal Mustafa
Enhanced airway reactivity and inflammation in A2A adenosine receptor-deficient allergic mice
Am J Physiol Lung Cell Mol Physiol, June 1, 2007; 292(6): L1335 - L1344.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
H. Sugiura, X. Liu, T. Kobayashi, S. Togo, R. F. Ertl, S. Kawasaki, K. Kamio, X. Q. Wang, L. Mao, L. Shen, et al.
Reactive Nitrogen Species Augment Fibroblast-Mediated Collagen Gel Contraction, Mediator Production, and Chemotaxis
Am. J. Respir. Cell Mol. Biol., May 1, 2006; 34(5): 592 - 599.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Ghosh, A. J. Janocha, M. A. Aronica, S. Swaidani, S. A. A. Comhair, W. Xu, L. Zheng, S. Kaveti, M. Kinter, S. L. Hazen, et al.
Nitrotyrosine Proteome Survey in Asthma Identifies Oxidative Mechanism of Catalase Inactivation
J. Immunol., May 1, 2006; 176(9): 5587 - 5597.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
W. Cao and Y. Duan
Breath Analysis: Potential for Clinical Diagnosis and Exposure Assessment
Clin. Chem., May 1, 2006; 52(5): 800 - 811.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
B. N. Chorley, Y. Li, S. Fang, J.-A. Park, and K. B. Adler
(R)-Albuterol Elicits Antiinflammatory Effects in Human Airway Epithelial Cells via iNOS
Am. J. Respir. Cell Mol. Biol., January 1, 2006; 34(1): 119 - 127.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
M. E. Poynter, R. L. Persinger, C. G. Irvin, K. J. Butnor, H. van Hirtum, W. Blay, N. H. Heintz, J. Robbins, D. Hemenway, D. J. Taatjes, et al.
Nitrogen dioxide enhances allergic airway inflammation and hyperresponsiveness in the mouse
Am J Physiol Lung Cell Mol Physiol, January 1, 2006; 290(1): L144 - L152.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
M L Wilsher, W Fergusson, D Milne, and A U Wells
Exhaled nitric oxide in sarcoidosis
Thorax, November 1, 2005; 60(11): 967 - 970.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
L. G. Que, L. Liu, Y. Yan, G. S. Whitehead, S. H. Gavett, D. A. Schwartz, and J. S. Stamler
Protection from Experimental Asthma by an Endogenous Bronchodilator
Science, June 10, 2005; 308(5728): 1618 - 1621.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
L. M. Hamilton, S. M. Puddicombe, R. J. Dearman, I. Kimber, T. Sandstrom, A. Wallin, P. H. Howarth, S. T. Holgate, S. J. Wilson, and D. E. Davies
Altered protein tyrosine phosphorylation in asthmatic bronchial epithelium
Eur. Respir. J., June 1, 2005; 25(6): 978 - 985.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
Y. Janssen-Heininger, K. Ckless, N. Reynaert, and A. van der Vliet
SOD Inactivation in Asthma: Bad News or NO News?
Am. J. Pathol., March 1, 2005; 166(3): 649 - 652.
[Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
S. A.A. Comhair, W. Xu, S. Ghosh, F. B.J.M. Thunnissen, A. Almasan, W. J. Calhoun, A. J. Janocha, L. Zheng, S. L. Hazen, and S. C. Erzurum
Superoxide Dismutase Inactivation in Pathophysiology of Asthmatic Airway Remodeling and Reactivity
Am. J. Pathol., March 1, 2005; 166(3): 663 - 674.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
J C Ojoo, S A Mulrennan, J A Kastelik, A H Morice, and A E Redington
Exhaled breath condensate pH and exhaled nitric oxide in allergic asthma and in cystic fibrosis
Thorax, January 1, 2005; 60(1): 22 - 26.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
S. A. Kharitonov and P. J. Barnes
Effects of Corticosteroids on Noninvasive Biomarkers of Inflammation in Asthma and Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, November 1, 2004; 1(3): 191 - 199.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
C. R. Morris, M. Poljakovic, L. Lavrisha, L. Machado, F. A. Kuypers, and S. M. Morris Jr.
Decreased Arginine Bioavailability and Increased Serum Arginase Activity in Asthma
Am. J. Respir. Crit. Care Med., July 15, 2004; 170(2): 148 - 153.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
J. Hjoberg, S. Shore, L. Kobzik, S. Okinaga, A. Hallock, J. Vallone, V. Subramaniam, G. T. De Sanctis, J. A. Elias, J. M. Drazen, et al.
Expression of nitric oxide synthase-2 in the lungs decreases airway resistance and responsiveness
J Appl Physiol, July 1, 2004; 97(1): 249 - 259.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
F. L. M. Ricciardolo, P. J. Sterk, B. Gaston, and G. Folkerts
Nitric Oxide in Health and Disease of the Respiratory System
Physiol Rev, July 1, 2004; 84(3): 731 - 765.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
P. E. Silkoff, F. A. Romero, N. Gupta, R. G. Townley, and H. Milgrom
Exhaled Nitric Oxide in Children With Asthma Receiving Xolair (Omalizumab), a Monoclonal Anti-Immunoglobulin E Antibody
Pediatrics, April 1, 2004; 113(4): e308 - e312.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
G Caramori and A Papi
Oxidants and asthma
Thorax, February 1, 2004; 59(2): 170 - 173.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
T. J. Toward, N. Smith, and K. J. Broadley
Effect of Phosphodiesterase-5 Inhibitor, Sildenafil (Viagra), in Animal Models of Airways Disease
Am. J. Respir. Crit. Care Med., January 15, 2004; 169(2): 227 - 234.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
A-C. Olin, E. Andersson, M. Andersson, G. Granung, S. Hagberg, and K. Toren
Prevalence of asthma and exhaled nitric oxide are increased in bleachery workers exposed to ozone
Eur. Respir. J., January 1, 2004; 23(1): 87 - 92.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
H. Kanazawa, S. Nomura, K. Hirata, and J. Yoshikawa
Effect of Inhaled Beclomethasone Dipropionate on Peroxynitrite Inhibitory Activity in Induced Sputum From Asthmatic Patients
Chest, November 1, 2003; 124(5): 1755 - 1761.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
F L M Ricciardolo, M C Timmers, J K Sont, G Folkerts, and P J Sterk
Effect of bradykinin on allergen induced increase in exhaled nitric oxide in asthma
Thorax, October 1, 2003; 58(10): 840 - 845.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
M. Ichinose, H. Sugiura, S. Yamagata, A. Koarai, M. Tomaki, H. Ogawa, Y. Komaki, P.J. Barnes, K. Shirato, and T. Hattori
Xanthine oxidase inhibition reduces reactive nitrogen species production in COPD airways
Eur. Respir. J., September 1, 2003; 22(3): 457 - 461.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
H. Numanami, D. K. Nelson, J. C. Hoyt, J. L. Freels, M. Habib, J. Amano, M. Haniuda, S. Koyama, and R. A. Robbins
Peroxynitrite Enhances Interleukin-10 Reduction in the Release of Neutrophil Chemotactic Activity
Am. J. Respir. Cell Mol. Biol., August 1, 2003; 29(2): 239 - 244.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
P. Maestrelli, C. Paska, M. Saetta, G. Turato, Y. Nowicki, S. Monti, B. Formichi, M. Miniati, and L.M. Fabbri
Decreased haem oxygenase-1 and increased inducible nitric oxide synthase in the lung of severe COPD patients
Eur. Respir. J., June 1, 2003; 21(6): 971 - 976.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
E. Nabeyrat, G. E. Jones, P. S. Fenwick, P. J. Barnes, and L. E. Donnelly
Mitogen-activated protein kinases mediate peroxynitrite-induced cell death in human bronchial epithelial cells
Am J Physiol Lung Cell Mol Physiol, June 1, 2003; 284(6): L1112 - L1120.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
H Sugiura, M Ichinose, S Yamagata, A Koarai, K Shirato, and T Hattori
Correlation between change in pulmonary function and suppression of reactive nitrogen species production following steroid treatment in COPD
Thorax, April 1, 2003; 58(4): 299 - 305.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
C. Nguyen, J.-L. Teo, A. Matsuda, M. Eguchi, E. Y. Chi, W. R. Henderson Jr., and M. Kahn
Chemogenomic identification of Ref-1/AP-1 as a therapeutic target for asthma
PNAS, February 4, 2003; 100(3): 1169 - 1173.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
F L M Ricciardolo
Multiple roles of nitric oxide in the airways
Thorax, February 1, 2003; 58(2): 175 - 182.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
P. R. Eynott, N. Paavolainen, D. A. Groneberg, A. Noble, M. Salmon, P. Nath, S.-Y. Leung, and K. F. Chung
Role of Nitric Oxide in Chronic Allergen-Induced Airway Cell Proliferation and Inflammation
J. Pharmacol. Exp. Ther., January 1, 2003; 304(1): 22 - 29.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
R. Piipari, P. Piirila, H. Keskinen, M. Tuppurainen, A. Sovijarvi, and H. Nordman
Exhaled nitric oxide in specific challenge tests to assess occupational asthma
Eur. Respir. J., December 1, 2002; 20(6): 1532 - 1537.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
L. R. Kisley, B. S. Barrett, A. K. Bauer, L. D. Dwyer-Nield, B. Barthel, A. M. Meyer, D. C. Thompson, and A. M. Malkinson
Genetic Ablation of Inducible Nitric Oxide Synthase Decreases Mouse Lung Tumorigenesis
Cancer Res., December 1, 2002; 62(23): 6850 - 6856.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
A. Warnholtz, H. Mollnau, T. Heitzer, A. Kontush, T. Moller-Bertram, D. Lavall, A. Giaid, U. Beisiegel, S. L. Marklund, U. Walter, et al.
Adverse effects of nitroglycerin treatment on endothelial function, vascular nitrotyrosine levels and cGMP-dependent protein kinase activity in hyperlipidemic Watanabe rabbits
J. Am. Coll. Cardiol., October 2, 2002; 40(7): 1356 - 1363.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
S A Kharitonov, L E Donnelly, P Montuschi, M Corradi, J V Collins, and P J Barnes
Dose-dependent onset and cessation of action of inhaled budesonide on exhaled nitric oxide and symptoms in mild asthma
Thorax, October 1, 2002; 57(10): 889 - 896.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
A. Koarai, M. Ichinose, H. Sugiura, M. Tomaki, M. Watanabe, S. Yamagata, Y. Komaki, K. Shirato, and T. Hattori
iNOS depletion completely diminishes reactive nitrogen-species formation after an allergic response
Eur. Respir. J., September 1, 2002; 20(3): 609 - 616.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
Members of the Task Force:, E. Baraldi, J.C. de Jongste, B. Gaston, K. Alving, P.J. Barnes, H. Bisgaard, A. Bush, C. Gaultier, H. Grasemann, et al.
Measurement of exhaled nitric oxide in children, 2001: E. Baraldi and J.C. de Jongste on behalf of the Task Force
Eur. Respir. J., July 1, 2002; 20(1): 223 - 237.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
H Kanazawa, S Shiraishi, K Hirata, and J Yoshikawa
Decreased peroxynitrite inhibitory activity in induced sputum in patients with bronchial asthma
Thorax, June 1, 2002; 57(6): 509 - 512.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. J. Whitekus, N. Li, M. Zhang, M. Wang, M. A. Horwitz, S. K. Nelson, L. D. Horwitz, N. Brechun, D. Diaz-Sanchez, and A. E. Nel
Thiol Antioxidants Inhibit the Adjuvant Effects of Aerosolized Diesel Exhaust Particles in a Murine Model for Ovalbumin Sensitization
J. Immunol., March 1, 2002; 168(5): 2560 - 2567.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
L. M. VAN DEN TOORN, S. E. OVERBEEK, J. C. DE JONGSTE, K. LEMAN, H. C. HOOGSTEDEN, and J.-B. PRINS
Airway Inflammation Is Present during Clinical Remission of Atopic Asthma
Am. J. Respir. Crit. Care Med., December 1, 2001; 164(11): 2107 - 2113.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
A. TERADA, T. FUJISAWA, K. TOGASHI, T. MIYAZAKI, H. KATSUMATA, J. ATSUTA, K. IGUCHI, H. KAMIYA, and H. TOGARI
Exhaled Nitric Oxide Decreases during Exercise-induced Bronchoconstriction in Children with Asthma
Am. J. Respir. Crit. Care Med., November 15, 2001; 164(10): 1879 - 1884.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
L. Lehtimaki, H. Kankaanranta, S. Saarelainen, V. Turjanmaa, and E. Moilanen
Inhaled fluticasone decreases bronchial but not alveolar nitric oxide output in asthma
Eur. Respir. J., October 1, 2001; 18(4): 635 - 639.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
R.B.R. Muijsers, N.H.T. ten Hacken, I. Van Ark, G. Folkerts, F.P. Nijkamp, and D.S. Postma
L-Arginine is not the limiting factor for nitric oxide synthesis by human alveolar macrophages in vitro
Eur. Respir. J., October 1, 2001; 18(4): 667 - 671.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
A. DUGUET, H. IIJIMA, S.-Y. EUM, Q. HAMID, and D. H. EIDELMAN
Eosinophil Peroxidase Mediates Protein Nitration in Allergic Airway Inflammation in Mice
Am. J. Respir. Crit. Care Med., October 1, 2001; 164(7): 1119 - 1126.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
S. LIM, K. TOMITA, G. CARRAMORI, A. JATAKANON, B. OLIVER, A. KELLER, I. ADCOCK, K. F. CHUNG, and P. J. BARNES
Low-dose Theophylline Reduces Eosinophilic Inflammation but Not Exhaled Nitric Oxide in Mild Asthma
Am. J. Respir. Crit. Care Med., July 15, 2001; 164(2): 273 - 276.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
T. J. Toward and K. J. Broadley
Chronic Lipopolysaccharide Exposure on Airway Function, Cell Infiltration, and Nitric Oxide Generation in Conscious Guinea Pigs: Effect of Rolipram and Dexamethasone
J. Pharmacol. Exp. Ther., July 1, 2001; 298(1): 298 - 306.
[Abstract] [Full Text]

Home page
 Eur Respir JHome page
S.J. Linnane, A.G. Thin, V.M. Keatings, J.B. Moynihan, P. McLoughlin, and M.X. FitzGerald
Glucocorticoid treatment reduces exhaled nitric oxide in cystic fibrosis patients
Eur. Respir. J., June 1, 2001; 17(6): 1267 - 1270.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
L. LEHTIMAKI, H. KANKAANRANTA, S. SAARELAINEN, P. HAHTOLA, R. JARVENPAA, T. KOIVULA, V. TURJANMAA, and E. MOILANEN
Extended Exhaled NO Measurement Differentiates between Alveolar and Bronchial Inflammation
Am. J. Respir. Crit. Care Med., June 1, 2001; 163(7): 1557 - 1561.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
S. A. KHARITONOV and P. J. BARNES
Exhaled Markers of Pulmonary Disease
Am. J. Respir. Crit. Care Med., June 1, 2001; 163(7): 1693 - 1722.
[Full Text] [PDF]

Home page
 ChestHome page
P. E. Silkoff, P. McClean, M. Spino, L. Erlich, A. S. Slutsky, and N. Zamel
Dose-Response Relationship and Reproducibility of the Fall in Exhaled Nitric Oxide After Inhaled Beclomethasone Dipropionate Therapy in Asthma Patients
Chest, May 1, 2001; 119(5): 1322 - 1328.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
E BARALDI and S ZANCONATO
The labyrinth of asthma phenotypes and exhaled NO
Thorax, May 1, 2001; 56(5): 333 - 335.
[Full Text]

Home page
 J. Immunol.Home page
J. C. MacPherson, S. A. A. Comhair, S. C. Erzurum, D. F. Klein, M. F. Lipscomb, M. S. Kavuru, M. K. Samoszuk, and S. L. Hazen
Eosinophils Are a Major Source of Nitric Oxide-Derived Oxidants in Severe Asthma: Characterization of Pathways Available to Eosinophils for Generating Reactive Nitrogen Species
J. Immunol., May 1, 2001; 166(9): 5763 - 5772.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
P. E. Silkoff, D. Martin, J. Pak, J. Y. Westcott, and R. J. Martin
Exhaled Nitric Oxide Correlated With Induced Sputum Findings in COPD
Chest, April 1, 2001; 119(4): 1049 - 1055.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
H. IIJIMA, A. DUGUET, S.-Y. EUM, Q. HAMID, and D. H. EIDELMAN
Nitric Oxide and Protein Nitration are Eosinophil Dependent in Allergen-Challenged Mice
Am. J. Respir. Crit. Care Med., April 1, 2001; 163(5): 1233 - 1240.
[Abstract] [Full Text]

</